JACOB GARY S
Insider CIK 1266802 · CLSP Chief Executive Officer, Director · TROV Director · SGYP Executive Chairman, Director · CTRV CEO and President, Director · VRPX Director · OKYO Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKYO OKYO Pharma Ltd | A Award | 2026-07-21 | 2026-07-23 | 3,500 | $1.40 | $4.9K | 112,420 | SEC↗ |
| OKYO OKYO Pharma Ltd | P Buy | 2026-07-21 | 2026-08-07 | 3,500 | $1.40 | $4.9K | 112,420 | SEC↗ |
| OKYO OKYO Pharma Ltd | P Buy | 2026-07-21 | 2026-08-07 | 3,500 | $1.40 | $4.9K | 112,420 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2024-02-19 | 2024-02-21 | 85,000 | — | $0 | 102,120 | SEC↗ |
| OKYO OKYO Pharma Ltd | P Buy | 2022-05-19 | 2022-05-19 | 12,500 | $4.00 | $50.0K | 12,500 | SEC↗ |
| VRPX Virpax Pharmaceuticals, In | A Award deriv | 2022-01-01 | 2022-01-05 | 12,091 | — | $0 | 12,091 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 28,858 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 44,734 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 293 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 218 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 223 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 223 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 530 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | J Other deriv | 2021-06-10 | 2021-06-15 | 755 | — | $0 | 76,106 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2021-05-18 | 2021-05-20 | 250,000 | — | $0 | 342,785 | SEC↗ |
| VRPX Virpax Pharmaceuticals, In | A Award deriv | 2021-04-07 | 2021-04-09 | 13,183 | — | $0 | 13,183 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-23 | 2021-03-23 | 1,900 | $10.42 | $19.8K | 21,452 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-23 | 2021-03-23 | 470 | $10.40 | $4.9K | 21,922 | SEC↗ |
| VRPX Virpax Pharmaceuticals, In | P Buy | 2021-02-17 | 2021-02-19 | 3,500 | $6.79 | $23.8K | 3,500 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | P Buy | 2020-12-01 | 2020-12-01 | 12,000 | $1.66 | $19.9K | 12,059 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2020-08-19 | 2020-08-21 | 30,000 | — | $0 | 92,785 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 28,858 | — | $0 | 76,106 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2020-05-14 | 2020-05-18 | 17,483 | $1.43 | $25.0K | 19,552 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2020-04-03 | 2020-04-07 | 60,000 | — | $0 | 62,729 | SEC↗ |
| HEPA Hepion Pharmaceuticals, In | A Award deriv | 2019-07-24 | 2019-07-25 | 970 | — | $0 | 2,729 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 44,734 | — | $0 | 48,071 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | P Buy deriv | 2018-07-03 | 2018-07-03 | 15 | $1000.00 | $15.0K | 15 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | P Buy deriv | 2018-07-03 | 2018-07-03 | 8,625 | $1000.00 | $8.63M | 8,625 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise deriv | 2018-06-15 | 2018-06-18 | 474,961 | — | $0 | 6,513,342 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | F Tax w/h | 2018-06-15 | 2018-06-18 | 150,246 | — | $0 | 595,460 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise | 2018-06-15 | 2018-06-18 | 474,961 | $0.50 | $237.5K | 877,640 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | F Tax w/h | 2018-06-15 | 2018-06-18 | 131,934 | — | $0 | 745,706 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2018-01-23 | 2018-01-25 | 54,322 | — | $0 | 248,101 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2018-01-05 | 2018-01-09 | 950,000 | — | $0 | 6,988,303 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 16,667 | — | $0 | 0 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 16,667 | — | $0 | 148,954 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-10-04 | 2017-10-05 | 38,106 | — | $0 | 193,779 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise deriv | 2017-09-02 | 2017-09-06 | 9,287 | — | $0 | 16,667 | SEC↗ |
| TROV Trovagene, Inc. | M Exercise | 2017-09-02 | 2017-09-06 | 9,287 | — | $0 | 132,287 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2017-06-28 | 2017-06-30 | 900,000 | — | $0 | 6,038,303 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | D To issuer deriv | 2017-06-28 | 2017-06-30 | 900,000 | — | $0 | 5,138,202 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | P Buy | 2017-05-26 | 2017-05-30 | 5,680 | $3.52 | $20.0K | 402,679 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-01-02 | 2017-01-04 | 16,667 | — | $0 | 16,667 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-01-02 | 2017-01-05 | 9,287 | — | $0 | 25,954 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2017-01-02 | 2017-01-05 | 16,667 | — | $0 | 16,667 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | A Award deriv | 2016-07-19 | 2016-07-20 | 65,000 | — | $0 | 1,015,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2016-06-24 | 2016-06-27 | 970,000 | — | $0 | 5,905,177 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2016-01-04 | 2016-01-06 | 16,000 | — | $0 | 155,673 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2015-09-29 | 2015-09-30 | 500,000 | — | $0 | 4,935,177 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2015-07-24 | 2015-07-28 | 300,000 | — | $0 | 4,435,177 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise deriv | 2015-07-01 | 2015-07-01 | 62,965 | — | $0 | 4,135,177 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | M Exercise | 2015-07-01 | 2015-07-01 | 62,965 | $5.61 | $353.2K | 396,999 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2015-03-17 | 2015-03-19 | 16,000 | — | $0 | 139,673 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2014-12-11 | 2014-12-15 | 15,667 | — | $0 | 123,673 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2014-12-06 | 2014-12-09 | 1,000,000 | — | $0 | 4,198,142 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | A Award deriv | 2014-12-03 | 2014-12-04 | 420,000 | — | $0 | 950,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2014-06-10 | 2014-06-12 | 300,000 | — | $0 | 3,198,142 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | P Buy | 2014-05-27 | 2014-05-28 | 4,000 | $4.18 | $16.7K | 338,034 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | A Award deriv | 2014-03-19 | 2014-03-20 | 300,000 | — | $0 | 530,000 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2014-02-25 | 2014-02-26 | 21,035 | — | $0 | 108,006 | SEC↗ |
| CTRV ContraVir Pharmaceuticals, | J Other | 2014-02-18 | 2014-02-20 | 32,935 | — | $0 | 32,935 | SEC↗ |
| NONE ContraVir Pharmaceuticals, | A Award deriv | 2014-01-24 | 2014-01-28 | 200,000 | — | $0 | 230,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-07-12 | 2013-07-16 | 100,000 | — | $0 | 2,898,142 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-07-12 | 2013-07-17 | 100,000 | — | $0 | 3,238,154 | SEC↗ |
| TROV TrovaGene Inc. | A Award deriv | 2013-02-14 | 2013-02-21 | 13,471 | — | $0 | 86,971 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 350,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 275,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 500,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 225,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 390,000 | — | $0 | 0 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer deriv | 2013-01-17 | 2013-01-22 | 150,000 | — | $0 | 0 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 70,161 | — | $0 | 3,138,154 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 40,478 | — | $0 | 3,067,993 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 26,985 | — | $0 | 3,027,515 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 62,965 | — | $0 | 3,000,530 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 49,473 | — | $0 | 2,937,565 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 89,950 | — | $0 | 2,888,092 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 40,478 | — | $0 | 3,067,993 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 26,985 | — | $0 | 3,027,515 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 62,965 | — | $0 | 3,000,530 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 49,473 | — | $0 | 2,937,565 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 89,950 | — | $0 | 2,888,092 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2013-01-17 | 2013-01-22 | 70,161 | — | $0 | 3,138,154 | SEC↗ |
| CLSP CALLISTO PHARMACEUTICALS I | D To issuer | 2013-01-17 | 2013-01-22 | 147,245 | — | $0 | 0 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award | 2013-01-17 | 2013-01-22 | 26,490 | — | $0 | 314,786 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award | 2013-01-17 | 2013-01-22 | 26,490 | — | $0 | 314,786 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2012-12-11 | 2012-12-13 | 600,000 | — | $0 | 2,798,142 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2012-08-07 | 2012-08-09 | 223,181 | — | $0 | 2,198,142 | SEC↗ |
| TROV TrovaGene Inc. | A Award deriv | 2012-01-26 | 2012-02-15 | 36,000 | — | $0 | 441,000 | SEC↗ |
| SGYP SYNERGY PHARMACEUTICALS, I | A Award deriv | 2011-12-29 | 2012-01-03 | 600,000 | — | $0 | 1,974,961 | SEC↗ |